Company Name:Exelixis, Inc.
CEO: Michael M. Morrissey

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in Alameda, CA.


Key numbers

Market Capitalization:7316883740
Shares Outstanding: 306659000
Float: 296096131
Next Earning Date:2020-08-06
TTm EPS: 0.968
TTm Dividend Rate:
200 days moving average:20.05
50 days moving average: 23.82
One day percent Change: -2.9



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,